These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27083144)

  • 1. Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 to afford protection against G-type nerve agents.
    Mata DG; Sabnekar P; Watson CA; Rezk PE; Chilukuri N
    Chem Biol Interact; 2016 Nov; 259(Pt B):233-241. PubMed ID: 27083144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of evolved paraoxonase-1 variants for prevention of organophosphorous pesticide compound intoxication.
    Mata DG; Rezk PE; Sabnekar P; Cerasoli DM; Chilukuri N
    J Pharmacol Exp Ther; 2014 Jun; 349(3):549-58. PubMed ID: 24706983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro and in vivo evaluation of the efficacy of recombinant human liver prolidase as a catalytic bioscavenger of chemical warfare nerve agents.
    Rezk PE; Zdenka P; Sabnekar P; Kajih T; Mata DG; Wrobel C; Cerasoli DM; Chilukuri N
    Drug Chem Toxicol; 2015 Jan; 38(1):37-43. PubMed ID: 24641262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
    Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
    Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification.
    Goldsmith M; Ashani Y; Simo Y; Ben-David M; Leader H; Silman I; Sussman JL; Tawfik DS
    Chem Biol; 2012 Apr; 19(4):456-66. PubMed ID: 22520752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
    Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
    Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in mice.
    Betapudi V; Goswami R; Silayeva L; Doctor DM; Chilukuri N
    Sci Transl Med; 2020 Jan; 12(527):. PubMed ID: 31969483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection.
    Hodgins SM; Kasten SA; Harrison J; Otto TC; Oliver ZP; Rezk P; Reeves TE; Chilukuri N; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):177-80. PubMed ID: 23123254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines.
    Curtin BF; Seetharam KI; Dhoieam P; Gordon RK; Doctor BP; Nambiar MP
    J Cell Biochem; 2008 Apr; 103(5):1524-35. PubMed ID: 17879943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
    Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
    J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.
    Gupta RD; Goldsmith M; Ashani Y; Simo Y; Mullokandov G; Bar H; Ben-David M; Leader H; Margalit R; Silman I; Sussman JL; Tawfik DS
    Nat Chem Biol; 2011 Feb; 7(2):120-5. PubMed ID: 21217689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
    Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
    Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.
    Valiyaveettil M; Alamneh YA; Doctor BP; Nambiar MP
    Toxicol Lett; 2012 Apr; 210(1):87-94. PubMed ID: 22301377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
    Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
    Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Characterization of New SsoPox Variant Points to the Dimer Interface as a Driver for the Increase in Promiscuous Paraoxonase Activity.
    Suzumoto Y; Dim O; Roviello GN; Worek F; Sussman JL; Manco G
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.